Lilly's triple-G obesity drug hits 28% weight loss in Phase 3; FDA clears the largest-ever liquid biopsy; EDEN, the 28B-parameter DNA foundation model, designs gene therapies from scratch

OpenAI launches ChatGPT for clinicians; ŌURA acquires Galen AI for unified health data; J&J partners with Viz.ai on hematoma detection

OpenAI launches GPT-Rosalind for drug discovery; Abridge expands into medical AI search with journal partnerships; FDA peptide reclassification unlocks telehealth GLP-1 market